CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta K. Pal, Samer A. Srour, Adrian G. Sacher et al.|Cancer Discovery|2024Cited by 137
Genomic landscape and clinical characteristics of patients (pts) with neuroendocrine prostate cancer (NEPC) with or without aggressive variant prostate cancer characterized by molecular signature (AVPC-MS).Hedyeh Ebrahimi, Alex Chehrazi‐Raffle, Regina Barragán-Carrillo et al.|Journal of Clinical Oncology|2025Cited by 1